SCHEDULE: Venrock Group Discloses 6.1% Stake in Adlai Nortye Ltd.
Beneficial Ownership Report
A group of Venrock entities and individuals has reported a 6.1% beneficial ownership stake in Adlai Nortye Ltd., totaling 9,638,193 ordinary shares.
Summary
- A group of Reporting Persons, including Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management III, LLC, VHCP Management EG, LLC, Nimish Shah, and Bong Koh, has filed a Schedule 13G.
- The Reporting Persons collectively beneficially own 9,638,193 ordinary shares of Adlai Nortye Ltd.
- This ownership represents 6.1% of Adlai Nortye Ltd.'s total ordinary shares outstanding.
- The ownership is primarily held through American Depositary Shares (ADS), with each ADS representing three ordinary shares.
- The group holds shared voting power and shared dispositive power over all 9,638,193 shares.
- The filing certifies that the securities were not acquired for the purpose of changing or influencing the control of Adlai Nortye Ltd.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive development, as it signifies a significant institutional investor's confidence in Adlai Nortye Ltd. by taking a substantial stake, though it is a passive investment.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that Schedule 13G filings are standard disclosures for passive investors acquiring significant stakes (5% or more) in public companies. Venrock's disclosure indicates a notable institutional interest in Adlai Nortye Ltd., a common occurrence in the biotechnology or pharmaceutical sectors where venture capital firms often hold substantial equity positions post-IPO or through private placements.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional ownership stake, potentially signaling confidence from a notable investor group.
- Management: Awareness of a large, passive institutional holder.
Key Dates
| Date | Description |
|---|---|
| 2025-06-30 | Date of ordinary shares outstanding reported in Issuer's Form 6-K. |
| 2025-12-29 | Date Issuer's Report of Foreign Private Issuer on Form 6-K was filed with the SEC, reporting shares outstanding as of June 30, 2025. |
| 2026-02-03 | Date Issuer's Report of Foreign Issuer on Form 6-K was filed with the SEC, reporting a private placement. |
| 2026-02-04 | Date of event requiring the Schedule 13G filing, corresponding to the closing of a private placement of equity securities by Adlai Nortye Ltd. |
| 2026-02-11 | Date of execution for the Power of Attorney for Bong Koh, Power of Attorney for Nimish Shah, and the Joint Filing Agreement. |
| 2026-02-11 | Date the Schedule 13G was signed and filed. |
Keywords
Adlai Nortye Ltd., Venrock, Schedule 13G, Beneficial Ownership, Ordinary Shares, ADS, Institutional Investor, Equity Stake, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.